Albemarle has been upgraded to a Buy by leading research firms, driven by a disciplined cost-cutting program that has already lowered annual fixed costs by over $200 million. Management’s recent asset sales of noncore facilities in North America generated more than $300 million in proceeds, which have been redeployed to high-margin lithium operations. These initiatives improve operating leverage and position Albemarle to convert even modest upticks in lithium prices into outsized earnings growth in 2026.

The company’s flagship mines at Salar de Atacama in Chile and the Greenbushes deposit in Australia remain industry-leading in quality and grade. Albemarle is completing a phased expansion at Atacama expected to add 60,000 metric tons of annual capacity by mid-2026, while a joint-venture upgrade at Greenbushes will boost throughput by 20%. Together, these projects underpin a forecasted 35% increase in lithium sales volume and solidify Albemarle’s status as the world’s largest lithium producer.

Following a recent outperformance rating from a top-tier brokerage, consensus forecasts for Albemarle’s 2026 EBITDA have risen by 18% over the past three months. Analysts cite robust EV battery order books and constrained supply growth as primary catalysts. Despite nearly half of the coverage universe still carrying hold or underperform recommendations, research teams are increasingly lifting earnings estimates and forecasting free cash flow generation of more than $2 billion next year.

Albemarle shares are on pace for a fourth consecutive weekly advance, more than doubling over the past nine months and trading at their highest level in two years. Technical support has held consistently at the 20-day moving average since early November. Options activity further underscores bullish sentiment: the 50-day put/call volume ratio recently fell to multiyear lows, and implied volatility sits in the lower quartile of its 12-month range, suggesting limited hedging demand and potential for additional upside.